Search research articles
Contact Us
Filters
Showing results (31-40 of 56) with videos related to
Page
of 6
Sort By:
Investigative Ophthalmology & Visual Science
|
August 1, 2013
Paraoxonase-1 is associated with corneal endothelial cell alterations in patients with chronic obstructive pulmonary disease
Núria Soler, Anabel García-Heredia, Judit Marsillach, et al.
Clinical and Experimental Pharmacology & Physiology
|
February 28, 2007
Administration of exogenous erythropoietin beta affects lipid peroxidation and serum paraoxonase-1 activity and concentration in predialysis patients with chronic renal disease and anaemia
Judit Marsillach, Albert Martínez-Vea, Luis Marcas, et al.
Antioxidants (Basel, Switzerland)
|
March 6, 2021
Paraoxonase-1 and -3 Protein Expression in the Brain of the Tg2576 Mouse Model of Alzheimer's Disease
Jose Gregorio Salazar, Judit Marsillach, Ingrid Reverte, et al.
Journal of Hepatology
|
March 3, 2006
Paraoxonase-1 is associated with oxidative stress, fibrosis and FAS expression in chronic liver diseases
Natàlia Ferré, Judit Marsillach, Jordi Camps, et al.
Journal of Molecular Histology
|
October 9, 2010
Tissue distribution and expression of paraoxonases and chemokines in mouse: the ubiquitous and joint localisation suggest a systemic and coordinated role
Fernando Rodríguez-Sanabria, Anna Rull, Raúl Beltrán-Debón, et al.
Mediators of Inflammation
|
June 15, 2013
Paraoxonase-1 inhibits oxidized low-density lipoprotein-induced metabolic alterations and apoptosis in endothelial cells: a nondirected metabolomic study
Anabel García-Heredia, Judit Marsillach, Anna Rull, et al.
Atherosclerosis
|
September 1, 2006
Serum paraoxonase-1 activity and concentration are influenced by human immunodeficiency virus infection
Sandra Parra, Carlos Alonso-Villaverde, Blai Coll, et al.
The Journal of Infectious Diseases
|
January 19, 2010
Paraoxonase-1 gene haplotypes are associated with metabolic disturbances, atherosclerosis, and immunologic outcome in HIV-infected patients
Sandra Parra, Judit Marsillach, Gerard Aragonés, et al.
Lipids in Health and Disease
|
May 18, 2010
Decreased paraoxonase-1 activity is associated with alterations of high-density lipoprotein particles in chronic liver impairment
Judit Marsillach, Gerard Aragonès, Bharti Mackness, et al.
Clinical Chemistry and Laboratory Medicine
|
August 8, 2012
Monocyte chemoattractant protein-1 and paraoxonase-1 and 3 levels in patients with sepsis treated in an intensive care unit: a preliminary report
Teresa Sans, Anna Rull, Jose Luna, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 56) with videos related to
Sort By:
Page
of 6
Investigative Ophthalmology & Visual Science
|
August 1, 2013
Paraoxonase-1 is associated with corneal endothelial cell alterations in patients with chronic obstructive pulmonary disease
Núria Soler, Anabel García-Heredia, Judit Marsillach, et al.
Clinical and Experimental Pharmacology & Physiology
|
February 28, 2007
Administration of exogenous erythropoietin beta affects lipid peroxidation and serum paraoxonase-1 activity and concentration in predialysis patients with chronic renal disease and anaemia
Judit Marsillach, Albert Martínez-Vea, Luis Marcas, et al.
Antioxidants (Basel, Switzerland)
|
March 6, 2021
Paraoxonase-1 and -3 Protein Expression in the Brain of the Tg2576 Mouse Model of Alzheimer's Disease
Jose Gregorio Salazar, Judit Marsillach, Ingrid Reverte, et al.
Journal of Hepatology
|
March 3, 2006
Paraoxonase-1 is associated with oxidative stress, fibrosis and FAS expression in chronic liver diseases
Natàlia Ferré, Judit Marsillach, Jordi Camps, et al.
Journal of Molecular Histology
|
October 9, 2010
Tissue distribution and expression of paraoxonases and chemokines in mouse: the ubiquitous and joint localisation suggest a systemic and coordinated role
Fernando Rodríguez-Sanabria, Anna Rull, Raúl Beltrán-Debón, et al.
Mediators of Inflammation
|
June 15, 2013
Paraoxonase-1 inhibits oxidized low-density lipoprotein-induced metabolic alterations and apoptosis in endothelial cells: a nondirected metabolomic study
Anabel García-Heredia, Judit Marsillach, Anna Rull, et al.
Atherosclerosis
|
September 1, 2006
Serum paraoxonase-1 activity and concentration are influenced by human immunodeficiency virus infection
Sandra Parra, Carlos Alonso-Villaverde, Blai Coll, et al.
The Journal of Infectious Diseases
|
January 19, 2010
Paraoxonase-1 gene haplotypes are associated with metabolic disturbances, atherosclerosis, and immunologic outcome in HIV-infected patients
Sandra Parra, Judit Marsillach, Gerard Aragonés, et al.
Lipids in Health and Disease
|
May 18, 2010
Decreased paraoxonase-1 activity is associated with alterations of high-density lipoprotein particles in chronic liver impairment
Judit Marsillach, Gerard Aragonès, Bharti Mackness, et al.
Clinical Chemistry and Laboratory Medicine
|
August 8, 2012
Monocyte chemoattractant protein-1 and paraoxonase-1 and 3 levels in patients with sepsis treated in an intensive care unit: a preliminary report
Teresa Sans, Anna Rull, Jose Luna, et al.
Page
of 6